WHO classification of tumors of hematopoietic and lymphoid tissues
GPTKB entity
Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:insurance
|
| gptkbp:alsoKnownAs |
WHO Blue Book
|
| gptkbp:classificationBasedOn |
morphology
clinical features genetic features immunophenotype |
| gptkbp:developedBy |
gptkb:World_Health_Organization
|
| gptkbp:edition |
4th edition (2008)
3rd edition (2001) Revised 4th edition (2017) |
| gptkbp:editor |
E. Campo
E.S. Jaffe N.L. Harris P. Jaffe S.H. Swerdlow |
| gptkbp:firstPublished |
2001
|
| gptkbp:focusesOn |
hematopoietic neoplasms
lymphoid neoplasms |
| gptkbp:includes |
gptkb:leukemia
gptkb:chronic_myeloid_leukemia gptkb:acute_myeloid_leukemia chronic lymphocytic leukemia myelodysplastic syndromes myeloproliferative neoplasms lymphomas plasma cell neoplasms |
| gptkbp:ISBN |
978-92-832-4494-3
|
| gptkbp:language |
English
|
| gptkbp:latestReleaseVersion |
2017
|
| gptkbp:partOf |
WHO Classification of Tumours series
|
| gptkbp:publishedBy |
gptkb:IARC
|
| gptkbp:relatedTo |
gptkb:International_Classification_of_Diseases
ICD-O coding |
| gptkbp:targetAudience |
medical researchers
oncologists pathologists hematologists |
| gptkbp:usedFor |
gptkb:diagnosis
prognosis treatment planning |
| gptkbp:website |
https://whobluebooks.iarc.fr/
|
| gptkbp:bfsParent |
gptkb:lymphocyte-depleted_Hodgkin_lymphoma
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
WHO classification of tumors of hematopoietic and lymphoid tissues
|